×
S&P 500   4,131.20 (+1.81%)
DOW   32,991.92 (+1.09%)
QQQ   306.91 (+2.53%)
AAPL   148.49 (+3.28%)
MSFT   270.58 (+1.76%)
FB   193.92 (+1.20%)
GOOGL   2,229.79 (+3.43%)
AMZN   2,266.05 (+2.00%)
TSLA   752.23 (+6.29%)
NVDA   185.89 (+4.13%)
BABA   93.28 (-1.27%)
NIO   16.42 (+2.43%)
AMD   101.46 (+2.74%)
CGC   4.88 (-12.07%)
MU   73.02 (+3.43%)
T   21.22 (-0.47%)
GE   77.88 (+1.13%)
F   13.56 (+3.35%)
DIS   108.40 (+2.64%)
AMC   13.95 (+14.06%)
PFE   53.56 (-0.80%)
PYPL   84.95 (+5.63%)
NFLX   194.27 (+1.50%)
S&P 500   4,131.20 (+1.81%)
DOW   32,991.92 (+1.09%)
QQQ   306.91 (+2.53%)
AAPL   148.49 (+3.28%)
MSFT   270.58 (+1.76%)
FB   193.92 (+1.20%)
GOOGL   2,229.79 (+3.43%)
AMZN   2,266.05 (+2.00%)
TSLA   752.23 (+6.29%)
NVDA   185.89 (+4.13%)
BABA   93.28 (-1.27%)
NIO   16.42 (+2.43%)
AMD   101.46 (+2.74%)
CGC   4.88 (-12.07%)
MU   73.02 (+3.43%)
T   21.22 (-0.47%)
GE   77.88 (+1.13%)
F   13.56 (+3.35%)
DIS   108.40 (+2.64%)
AMC   13.95 (+14.06%)
PFE   53.56 (-0.80%)
PYPL   84.95 (+5.63%)
NFLX   194.27 (+1.50%)
S&P 500   4,131.20 (+1.81%)
DOW   32,991.92 (+1.09%)
QQQ   306.91 (+2.53%)
AAPL   148.49 (+3.28%)
MSFT   270.58 (+1.76%)
FB   193.92 (+1.20%)
GOOGL   2,229.79 (+3.43%)
AMZN   2,266.05 (+2.00%)
TSLA   752.23 (+6.29%)
NVDA   185.89 (+4.13%)
BABA   93.28 (-1.27%)
NIO   16.42 (+2.43%)
AMD   101.46 (+2.74%)
CGC   4.88 (-12.07%)
MU   73.02 (+3.43%)
T   21.22 (-0.47%)
GE   77.88 (+1.13%)
F   13.56 (+3.35%)
DIS   108.40 (+2.64%)
AMC   13.95 (+14.06%)
PFE   53.56 (-0.80%)
PYPL   84.95 (+5.63%)
NFLX   194.27 (+1.50%)
S&P 500   4,131.20 (+1.81%)
DOW   32,991.92 (+1.09%)
QQQ   306.91 (+2.53%)
AAPL   148.49 (+3.28%)
MSFT   270.58 (+1.76%)
FB   193.92 (+1.20%)
GOOGL   2,229.79 (+3.43%)
AMZN   2,266.05 (+2.00%)
TSLA   752.23 (+6.29%)
NVDA   185.89 (+4.13%)
BABA   93.28 (-1.27%)
NIO   16.42 (+2.43%)
AMD   101.46 (+2.74%)
CGC   4.88 (-12.07%)
MU   73.02 (+3.43%)
T   21.22 (-0.47%)
GE   77.88 (+1.13%)
F   13.56 (+3.35%)
DIS   108.40 (+2.64%)
AMC   13.95 (+14.06%)
PFE   53.56 (-0.80%)
PYPL   84.95 (+5.63%)
NFLX   194.27 (+1.50%)
LON:DXRX

Diaceutics (DXRX) Share Forecast, Price & News

GBX 111.90
+1.40 (+1.27%)
(As of 05/27/2022 11:09 AM ET)
Add
Compare
Today's Range
111.90
112
50-Day Range
98
122
52-Week Range
97
130
Volume
6,186 shs
Average Volume
54,281 shs
Market Capitalization
£94.33 million
P/E Ratio
159.86
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive DXRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter.

Diaceutics logo

About Diaceutics

Diaceutics PLC provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories, which provides lab mapping, testing dashboard, and physician mapping services. The company also provides DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics in a secure and standardized way. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is based in Belfast, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceuticals: Other
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Phone
N/A
Fax
N/A
Employees
133
Year Founded
N/A

Sales & Book Value

Annual Sales
£13.94 million
Cash Flow
GBX 23.48 per share
Book Value
GBX 48.40 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£94.33 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.21 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -













Diaceutics (LON:DXRX) Frequently Asked Questions

Who are Diaceutics' key executives?
Diaceutics' management team includes the following people:
  • Mr. Peter Keeling, Founder, CEO & Exec. Director (Age 60, Pay $273.3k)
  • Mr. Ryan Keeling, Chief Innovation Officer & Exec. Director (Age 39, Pay $225.32k)
  • Mr. Philip H. White F.C.A., Exec. Officer (Age 46, Pay $223.12k)
  • Mr. Nicholas Stewart Roberts, CFO & Director (Age 39)
  • Ms. Julie Browne, Chief Operating Officer
  • Ms. Zarina Bibi, VP & Gen. Counsel
  • Ms. Jillian Beggs, VP of Sales & Marketing
  • Ms. Norma Thompson, Global Head of HR
  • Mr. Jordan Clark, Chief Commercial Officer
  • Ms. Susanne Munksted, Chief Precision Officer
What is Diaceutics' stock symbol?

Diaceutics trades on the London Stock Exchange (LON) under the ticker symbol "DXRX."

How do I buy shares of Diaceutics?

Shares of DXRX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Diaceutics' stock price today?

One share of DXRX stock can currently be purchased for approximately GBX 111.90.

How much money does Diaceutics make?

Diaceutics has a market capitalization of £94.33 million and generates £13.94 million in revenue each year.

How many employees does Diaceutics have?

Diaceutics employs 133 workers across the globe.

What is Diaceutics' official website?

The official website for Diaceutics is www.diaceutics.com.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.